The assay involves screening for inhibitors of the interaction between thyroid receptor and steroid receptor coregulator 2 using a fluorescence polarization assay. The assay measures total fluorescence and identifies potential fluorescent and light absorbing compounds that may interfere with the accuracy of the assay. The goal is to identify inhibitors that can be used in potential therapeutics for obesity and hyperlipidemias without undesirable side effects. Is the molecule effective to this assay?